| scholarly article | Q13442814 |
| P50 | author | James David Jentsch | Q29667844 |
| Christopher D Verrico | Q60326880 | ||
| P2093 | author name string | Robert H Roth | |
| P433 | issue | 1 | |
| P921 | main subject | selective reduction | Q3153583 |
| dopamine | Q170304 | ||
| cannabinoids | Q422936 | ||
| P304 | page(s) | 61-66 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Synapse | Q7662025 |
| P1476 | title | Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats | |
| P478 | volume | 49 |
| Q34714161 | A new approach to researching the etiology of cannabis use disorder: integrating transmissible and nontransmissible risk within a developmental framework |
| Q33838292 | Abnormal cerebellar morphometry in abstinent adolescent marijuana users |
| Q34381331 | Cannabinoid modulation of alpha2 adrenergic receptor function in rodent medial prefrontal cortex |
| Q35754854 | Cannabinoid modulation of cortical adrenergic receptors and transporters |
| Q37734568 | Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders. |
| Q31095554 | Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? |
| Q50993509 | Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings. |
| Q22242611 | Cannabis and psychiatric disorders: it is not only addiction |
| Q22252549 | Cannabis and psychosis: Have we found the missing links? |
| Q82188891 | Cannabis consumption and risk of developing schizophrenia: myth or reality? |
| Q47328661 | Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism |
| Q51795673 | Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence. |
| Q37160448 | Cannabis, cannabinoids and schizophrenia: integration of the evidence |
| Q50963559 | Cannabis-related deficits in real-world memory. |
| Q51922203 | Cognitive and neuropsychiatric consequences of endocannabinoid signaling dysfunction. |
| Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
| Q34290364 | Drugs of abuse and increased risk of psychosis development. |
| Q33886277 | Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans |
| Q52147129 | Maternal separation and early stress cause long-lasting effects on dopaminergic and endocannabinergic systems and alters dendritic morphology in the nucleus accumbens and frontal cortex in rats. |
| Q28533998 | Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans |
| Q34103173 | Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists |
| Q37341421 | Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects |
| Q47762220 | Psychedelic symptoms of cannabis and cocaine use as a function of trait impulsivity |
| Q44705377 | Repeated, intermittent delta(9)-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention |
| Q90124577 | Stress and drug abuse-related disorders: The promising therapeutic value of neurosteroids focus on pregnenolone-progesterone-allopregnanolone pathway |
| Q50716534 | Subjective effects of cannabis before the first psychotic episode. |
| Q36358712 | Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate |
| Q34469382 | The Influence of Recency of Use on fMRI Response During Spatial Working Memory in Adolescent Marijuana Users |
| Q50980365 | The differential effect of illicit drug use on cognitive function in first-episode psychosis and healthy controls. |
| Q33641039 | The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample |
| Q50000332 | The interaction between cannabis use and the Val158Met polymorphism of the COMT gene in psychosis: A transdiagnostic meta - analysis |
| Q37142233 | The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction. |
| Q34581117 | Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors |
Search more.